Amruta Pediacare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.49 M
as on 27-12-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.25 Cr
as on 27-12-2024
- Satisfied Charges ₹ 3.98 Cr
as on 27-12-2024
- Revenue 43.21%
(FY 2022)
- Profit 213.15%
(FY 2022)
- Ebitda 1853.21%
(FY 2022)
- Net Worth 21.82%
(FY 2022)
- Total Assets 35.14%
(FY 2022)
About Amruta Pediacare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹6.25 Cr. The company has closed loans amounting to ₹3.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Samir Thakrar, Jay Dhirwani, Nayankumar Kalawadia, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ2009PTC058107
- Company No.
058107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Amruta Pediacare?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Thakrar  | Director | 14-Sep-2009 | Current |
| Jay Dhirwani | Director | 14-Sep-2009 | Current |
| Nayankumar Kalawadia | Director | 14-Sep-2009 | Current |
| Chetan Patel | Director | 14-Sep-2009 | Current |
| Rakeshkumar Patel | Director | 14-Sep-2009 | Current |
| Dharmendra Upadhyay | Director | 14-Sep-2009 | Current |
Financial Performance of Amruta Pediacare.
Amruta Pediacare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.21% increase. The company also saw a substantial improvement in profitability, with a 213.15% increase in profit. The company's net worth Soared by an impressive increase of 21.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amruta Pediacare?
In 2019, Amruta Pediacare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Dec 2020 | ₹6.00 Cr | Open |
The Co-Operative Bank Of Rajkot Ltd Creation Date: 02 Jan 2014 | ₹2.50 M | Open |
The Co-Operative Bank Of Rajkot Ltd. Creation Date: 17 Dec 2013 | ₹1.08 Cr | Satisfied |
How Many Employees Work at Amruta Pediacare?
Amruta Pediacare has a workforce of 119 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amruta Pediacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amruta Pediacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
